Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00505245 · ClinicalTrials.gov registry record
New Assessment System in Measuring Symptom Distress in Cancer Patients
A clinical trial of Malignant Neoplasm and Caregiver, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- 6,500
- Enrollment target
- 1
- Study location
NCT00505245: Recruiting study of Malignant Neoplasm and Caregiver, sponsored by M.D. Anderson Cancer Center.
NCT00505245 is a study of Malignant Neoplasm and Caregiver that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 6,500 participants, above the 403-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (1513% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00505245, a study of Malignant Neoplasm and Caregiver, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- 6,500 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in patients due to cancer and its treatment and how the symptoms impact quality of life.
Primary Outcome
Each item is rated 0 to 10 with 0 = symptom not present or no interference and 10 meaning the symptom severity is as bad as can be imaged or complete interference. The symptom severity and interference sub scales are mean values of the items in each scale. Hence the range of each sub scale is also 0 to 10. Lower values represent a better outcome. Higher values represent a worse outcome. The symptom severity and interference sub scales are not combined to compute a total score.
Conditions Studied
Interventions
- OTHER Quality-of-Life Assessment
- OTHER Questionnaire Administration
- OTHER Interview
Study Locations (1)
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6,500 participants |
| Start Date | 1999-04-13 |
| Est. Completion | 2031-04-30 |
What NCT00505245 shows while recruiting
NCT00505245 is an observational study that tracks outcomes without assigning an intervention. Its 6,500 participants enrollment target places it among the larger protocols in the corpus, above the 403-participant average among 59 other Malignant Neoplasm trials with a reported enrollment target (1513% higher).
The record links to 4 conditions, with Malignant Neoplasm appearing as the primary indexed condition, and to 3 interventions - of which Quality-of-Life Assessment is the first listed.
NCT00505245 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00505245 about?
NCT00505245 is a clinical study titled "New Assessment System in Measuring Symptom Distress in Cancer Patients". This trial studies how well a new assessment system (MDASI or other MD Anderson-developed PRO instrument) works in measuring symptoms and the impact on quality of life in cancer patients. Development of a new assessment system may provide more information about the common symptoms that may occur in ...
What is the current status of trial NCT00505245?
This trial is currently recruiting. The enrollment target is 6,500 participants. The study started on 1999-04-13. Estimated completion is 2031-04-30.
What conditions does trial NCT00505245 study?
This clinical trial studies the following conditions: Malignant Neoplasm, Caregiver, Health Care Provider, Physician.
What interventions are being tested in trial NCT00505245?
The interventions under investigation include: Quality-of-Life Assessment (OTHER), Questionnaire Administration (OTHER), Interview (OTHER).
Who is sponsoring clinical trial NCT00505245?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00505245 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Malignant Neoplasm
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00505245's enrollment target sits among peer trials
6,500 2nd of 59 the highest of 59 other Malignant Neoplasm trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Malignant Neoplasm trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
RECRUITING · Phase 1
-
Pre-operative SRS or Post-operative SRS in Treating Cancer Patients With Brain Metastases
RECRUITING · Phase 3
-
Germ-Line Mutations in Blood and Saliva Samples From Patients With Cancer
RECRUITING
-
A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents
RECRUITING · Phase 1
-
Engagement of American Indians of Southwestern Tribal Nations in Cancer Genome Sequencing
RECRUITING · NA
-
A Study to Evaluate the Safety and Efficacy of MK-3120 in Participants With Advanced Solid Tumors (MK-3120-002)
RECRUITING · Phase 1
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06821009 · 6,500 participants · NA
Effectiveness of a Cloud-based Digital Health Navigation Program for Colorectal Cancer Screening
- NCT05369429 · 6,516 participants · NA
My Wellbeing Guide: a Novel Tool for Managing Stress and Improving Quality of Life
- NCT05143697 · 6,600 participants · NA
Motivational Wellness Coaching to Reduce Childhood Obesity in Families and Kids
- NCT05515224 · 6,600 participants · NA
5-Cog 2.0: A Pragmatic Clinical Trial
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI